Looking across Empagliflozin Evidence Spectrum from Randomized Controlled Trial to Real-World Evidence

  • Prof. Dr. dr. Imam Subekti, Sp. PD – KEMD

    Speaker

  • Dr. dr. Soebagijo Adi Soelistijo, Sp. PD – KEMD

    Moderator

  • , ,